Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

被引:5
|
作者
Arslan, Derya [1 ]
Buyukinan, Muammer [2 ]
Uysal, Celil [3 ]
Deniz, Cigdem Damla [4 ]
机构
[1] Konya Training & Res Hosp, Univ Hlth Sci, Dept Pediat Cardiol, Konya, Turkey
[2] Konya Training & Res Hosp, Dept Pediat Endocrinol, Konya, Turkey
[3] Patnos State Hosp, Dept Pediat, Agri, Turkey
[4] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
关键词
Subclinical hypothyroidism; Cardiovascular risk; GDF-15; Child; HEART-FAILURE; GUIDELINES; ECHOCARDIOGRAPHY; ASSOCIATION; CHILDHOOD; HORMONE; DISEASE;
D O I
10.1007/s12020-019-01933-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Subclinical hypothyroidism, defined as increased TSH serum levels and normal serum free T4 concentrations, has been associated with an increased risk of heart disease in adults. But, data in children and adolescents are scanty and treatment of subclinical hypothyroidism is controversial. Growth differentiation factor-15 (GDF-15) is a promising biomarker of cardiac remodeling. This study aimed to evaluate the cardiovascular risk factors in children with subclinical hypothyroidism, measured with tissue Doppler echocardiography (TDE), and conventional echocardiography and GDF-15 level. Methods The study comprised a total of 41 pediatric patients with subclinical hypothyroidism (SH) (mean age 9.6 +/- 4.7 years) and 31 healthy children (mean age 11.2 +/- 3.4 years) as the control group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Tissue Doppler echocardiography was performed to all individuals in the control group and patient group at the beginning of the study. Global systolic function as assessed by left ventricular ejection fraction was compared between groups. The serum GDF-15 level was measured. Results There were no significant differences in demographic parameters between the SH and control groups. The left ventricular internal diameter end systole, interventricular septal end diastole, left ventricular posterior wall end diastole, and tricuspid annular plane systolic excursion values were significantly different between the SH and control groups (p = 0.038, 0.028, 0.005, and 0.000, respectively). The mean mitral isovolumic relaxation time value of the SH group was 57.2 +/- 9.3 ms, compared to 44.5 +/- 5.6 ms for the control group (p = 0.000). The mean tricuspid isovolumic contraction time value of the SH group was 58.7 +/- 9.4 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). The mean tricuspid isovolumic relaxation time value of the SH group was 58.03 +/- 9.5 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). There were no significant differences in the other m-mode or pulse Doppler echocardiography values between two groups. The GDF-15 value of the SH group was 382.6 +/- 268.2 pg/mL, and that of the control group was 473.6 +/- 337.9 pg/mL; this difference was not significant. Conclusion Patients with subclinical hypothyroidism versus healthy individuals had some changes in echocardiographic parameters that indicate involvement of diastolic function of the left ventricle. They were significantly different when compared SH group and the control group. This study demonstrated ventricle diastolic dysfunction in pediatric patients with hypothyroidism. The results of our study suggest that cardiac follow-up may be useful in patients with subclinical hypothyroidism and clinical trials are needed to explore therapeutic effects of T4 and T3 administration in this patients.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [31] The Association of Growth Differentiation Factor-15 Gene Polymorphisms with Growth Differentiation Factor-15 Serum Levels and Risk of Ischemic Stroke
    Xiang, Yang
    Zhang, Ting
    Guo, Jing
    Peng, You-Fan
    Wei, Ye-Sheng
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (10): : 2111 - 2119
  • [32] Growth Differentiation Factor-15: a New Biomarker in Cardiovascular DiseaseGrowth Differentiation Factor-15: ein neuer kardiovaskulärer Biomarker
    Tibor Kempf
    Kai C. Wollert
    Herz, 2009, 34 : 594 - 599
  • [33] Prognostic value of growth-differentiation factor-15 in patients with ST-elevation myocardial infarction
    Kempf, Tibor
    Peter, Timo
    James, Stefan
    Lindahl, Bertil
    Drexler, Helmut
    Wollert, Kai C.
    Wallentin, Lars
    CIRCULATION, 2006, 114 (18) : 422 - 423
  • [34] Growth-differentiation factor-15 expression in anemia of chronic disease and iron-deficiency anemia
    Abdullah, Noor Sabeeh
    Ahmed, Abeer Anwer
    IRAQI JOURNAL OF HEMATOLOGY, 2020, 9 (02) : 61 - 65
  • [35] Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy
    Tantawy, Azza Abdel Gawad
    Adly, Amira Abdel Moneam
    Ismail, Eman Abdel Rahman
    Youssef, Omneya Ibrahim
    Ali, Mohamed ElSayed
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (02) : 144 - 150
  • [36] Study of growth differentiation factor-15 in polytransfused children with β-thalassemia
    Meena, Swati
    Sharma, Kusha
    Sharma, Sunita
    Chandra, Jagdish
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 81 - 84
  • [37] Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease
    Nyarady, Balazs Bence
    Kiss, Loretta Zsuzsa
    Bagyura, Zsolt
    Merkely, Bela
    Dosa, Edit
    Lang, Orsolya
    Kohidai, Laszlo
    Pallinger, Eva
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [38] Growth differentiation factor-15 and its role in diabetes and cardiovascular disease
    Eddy, Adrian C.
    Trask, Aaron J.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 57 : 11 - 18
  • [39] Growth Differentiation Factor-15 Level and Tissue Doppler Echocardiography as a Tool in Identification of Cardiac Effects in the Children with Type 1 Diabetes Mellitus
    Uysal, Celil
    Arslan, Derya
    Buyukinan, Muammer
    Gederet, Yavuz Turgut
    Vatansev, Husamettin
    Ozcelik, Huseyin Samet
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (08) : 574 - 580
  • [40] Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease Results From the AtheroGene Study
    Kempf, Tibor
    Sinning, Jan-Malte
    Quint, Anja
    Bickel, Christoph
    Sinning, Christoph
    Wild, Philipp S.
    Schnabel, Renate
    Lubos, Edith
    Rupprecht, Hans J.
    Muenzel, Thomas
    Drexler, Helmut
    Blankenberg, Stefan
    Wollert, Kai C.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2009, 2 (03) : 286 - 292